Abstract:Results from previous studies on the role of autophagy of β‐cell function together with its implication in the development of diabetes are discussed. As β‐cell failure is an ultimate cause of diabetes and also that of unresponsiveness to the conventional therapy, modulation of β‐cell autophagy could be a future antidiabetic modality, particularly for patients who are not well managed with current antidiabetic therapy. Elucidating the molecular mechanism of autophagy was a landmark in understanding not only the physiology of cells and tissues, but also the pathogenesis of diverse diseases, including diabetes and metabolic disorders. Autophagy of pancreatic β‐cells plays a pivotal role in the maintenance of the mass, structure and function of β‐cells, whose dysregulation can lead to abnormal metabolic profiles or diabetes. Modulators of autophagy are being developed to improve metabolic profile and β‐cell function through the removal of harmful materials and rejuvenation of organelles, such as mitochondria and endoplasmic reticulum. Among the known antidiabetic drugs, glucagon‐like peptide‐1 receptor agonists enhance the autophagic activity of β‐cells, which might contribute to the profound effects of glucagon‐like peptide‐1 receptor agonists on systemic metabolism. In this review, the results from studies on the role of autophagy in β‐cells and their implication in the development of diabetes are discussed. In addition to non‐selective (macro)autophagy, the role and mechanisms of selective autophagy and other minor forms of autophagy that might occur in β‐cells are discussed. As β‐cell failure is the ultimate cause of diabetes and unresponsiveness to conventional therapy, modulation of β‐cell autophagy might represent a future antidiabetic treatment approach, particularly in patients who are not well managed with current antidiabetic therapy.

Pancreatic β-Cells, Diabetes and Autophagy

Role of β‐cell autophagy in β‐cell physiology and the development of diabetes

The Role of Autophagy in Endoplasmic Reticulum Stress-Induced Pancreatic Β Cell Death

Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetes

Autophagy in diabetes: β-cell dysfunction, insulin resistance, and complications

Autophagy and the pancreas: Healthy and disease states

Role of autophagy in the progression from obesity to diabetes and in the control of energy balance

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

The role of autophagy in the treatment of type II diabetes and its complications: a review

Interaction between Autophagy and Senescence in Pancreatic Beta Cells

Mitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes

The Role of Autophagy of Endothelial Cells in Diabetic Vascular Diseases

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Pancreas Β Cell Regeneration and Type 1 Diabetes (Review)

Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications

Autophagy and Mitochondria in Obesity and Type 2 Diabetes

The relationship between HMGB1 and autophagy in the pathogenesis of diabetes and its complications

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

The role of autophagy in insulin resistance and glucolipid metabolism and potential use of autophagy modulating natural products in the treatment of type 2 diabetes mellitus

Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential

Pancreatic regulation of glucose homeostasis